Background: Non-melanoma skin cancer (NMSC) incidence has been increasing steadily around the world. The aim of the study is to describe geographic trends in incidence and mortality of NMSC in Russia between 2007 and 2017 and compare findings to other European countries. Methods: We used geospatial analysis to map the incident cases and descriptive statistical analysis to analyze trends. Additionally, we assessed the relationship between ethnicity, geographic latitude/longitude, and NMSC incidence/mortality rates. We retrospectively analyzed the data from the Moscow Oncology Research Institute, Ministry of Health of the Russian Federation, for 2007–2017. Routine methods of descriptive epidemiology were used to study incidence and mortality rates by age groups, years, and jurisdictions (i.e., Federal Districts and Federal Subjects). Results: In total, 733,723 patients were diagnosed with NMSC in Russia over the period 2007–2017, of whom 63% were women. The overall age-standardized incidence and mortality rates were 29.64/100,000 and 0.70/100,000, respectively. There was a consistent increase in age-standardized incidence rates over the study period, with a decreasing mortality rate. Geographic mapping revealed north-to-south and east-to-west gradients for NMSC. Conclusions: This study demonstrated longitudinal trends for NMSC incidence in Russia documenting that skin phototype, latitude/longitude, climate zones, and cultural practices remain dominant risk factors defining the epidemiology of NMSC. Moreover, this work identified several regions in the country (i.e., Republic of Adygea, Samara, Krasnodar Krai, etc.), where patient education/sun awareness campaigns will be useful to help reduce the risk of this malignancy.

1.
Hannuksela-Svahn
A
,
Pukkala
E
,
Karvonen
J
.
Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995
.
Arch Dermatol
.
1999
Jul
;
135
(
7
):
781
6
.
[PubMed]
0003-987X
2.
Leiter
U
,
Garbe
C
.
Epidemiology of melanoma and nonmelanoma skin cancer—the role of sunlight
.
Adv Exp Med Biol
.
2008
;
624
:
89
103
.
[PubMed]
0065-2598
3.
Xiang
F
,
Lucas
R
,
Hales
S
,
Neale
R
.
Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships
.
JAMA Dermatol
.
2014
Oct
;
150
(
10
):
1063
71
.
[PubMed]
2168-6068
4.
Moan
J
,
Grigalavicius
M
,
Baturaite
Z
,
Dahlback
A
,
Juzeniene
A
.
The relationship between UV exposure and incidence of skin cancer
.
Photodermatol Photoimmunol Photomed
.
2015
Jan
;
31
(
1
):
26
35
.
[PubMed]
0905-4383
5.
Rosso
S
,
Zanetti
R
,
Martinez
C
,
Tormo
MJ
,
Schraub
S
,
Sancho-Garnier
H
, et al.
The multicentre south European study ‘Helios’. II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin
.
Br J Cancer
.
1996
Jun
;
73
(
11
):
1447
54
.
[PubMed]
0007-0920
6.
Qureshi
AA
,
Laden
F
,
Colditz
GA
,
Hunter
DJ
.
Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma
.
Arch Intern Med
.
2008
Mar
;
168
(
5
):
501
7
.
[PubMed]
0003-9926
7.
Ramos
J
,
Villa
J
,
Ruiz
A
,
Armstrong
R
,
Matta
J
.
UV dose determines key characteristics of nonmelanoma skin cancer
.
Cancer Epidemiol Biomarkers Prev
.
2004
Dec
;
13
(
12
):
2006
11
.
[PubMed]
1055-9965
8.
Ko
CB
,
Walton
S
,
Keczkes
K
,
Bury
HP
,
Nicholson
C
.
The emerging epidemic of skin cancer
.
Br J Dermatol
.
1994
Mar
;
130
(
3
):
269
72
.
[PubMed]
0007-0963
9.
Staples
M
,
Marks
R
,
Giles
G
.
Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?
Int J Cancer
.
1998
Oct
;
78
(
2
):
144
8
.
[PubMed]
0020-7136
10.
Lomas
A
,
Leonardi-Bee
J
,
Bath-Hextall
F
.
A systematic review of worldwide incidence of nonmelanoma skin cancer
.
Br J Dermatol
.
2012
May
;
166
(
5
):
1069
80
.
[PubMed]
0007-0963
11.
Corrêa
MP
,
Dubuisson
P
,
Plana-Fattori
A
.
An overview of the ultraviolet index and the skin cancer cases in Brazil
.
Photochem Photobiol
.
2003
Jul
;
78
(
1
):
49
54
.
[PubMed]
0031-8655
12.
Malone
JP
,
Fedok
FG
,
Belchis
DA
,
Maloney
ME
.
Basal cell carcinoma metastatic to the parotid: report of a new case and review of the literature.
Ear Nose Throat J.
2000
Jul
;79(7):511-5, 18-9.
13.
Cherpelis
BS
,
Marcusen
C
,
Lang
PG
.
Prognostic factors for metastasis in squamous cell carcinoma of the skin
.
Dermatol Surg
.
2002
Mar
;
28
(
3
):
268
73
.
[PubMed]
1076-0512
14.
Kaprina
AD
,
Petrova
GV
.
Malignancies in Russia in 2014 (morbidity and mortality)
.
RIIS FIAN
;
2015
. p.
249
.
15.
Merabishvili
VM
. Malignant tumors in St.-Petersburg (analysis of cancer registry database according to international standards: morbidity, mortality, survival). Saint-Petersburg: Ladoga;
2015
.
16.
Merabishvili
VM
. Oncological statistics (traditional methods, new information technologies). Guidelines for physicians. Part I. Second ed. St.-Petersburg:
2015
.
17.
Merabishvili
VM
. Oncological Statistics (traditional methods, new information technologies). Guidelines for physicians. Part 2A. Second ed. St.-Petersburg: SPb, COSTA;
2015
.
18.
Kaprina
AD
,
Starinsky
VV
,
Petrova
GV
. Malignant neoplasma in Russia in 2017 (morbidity and mortality). Russia, Moscow: P.A. Herzen branch of the FGBU "NMITS of radiology" of the Ministry of Health;
2018
.
19.
Ghazawi
FM
,
Cyr
J
,
Darwich
R
,
Le
M
,
Rahme
E
,
Moreau
L
, et al.
Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study
.
J Am Acad Dermatol
.
2019
Feb
;
80
(
2
):
448
59
.
[PubMed]
0190-9622
20.
Ghazawi
FM
,
Darwich
R
,
Le
M
,
Rahme
E
,
Zubarev
A
,
Moreau
L
, et al.
Uveal melanoma incidence trends in Canada: a national comprehensive population-based study
.
Br J Ophthalmol
.
2019
Dec
;
103
(
12
):
1872
6
.
[PubMed]
0007-1161
21.
Ghazawi
FM
,
Le
M
,
Lagacé
F
,
Cyr
J
,
Alghazawi
N
,
Zubarev
A
, et al.
Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada
.
J Cutan Med Surg
.
2019
Jul/Aug
;
23
(
4
):
394
412
.
[PubMed]
1203-4754
22.
Muntyanu
A
,
Savin
E
,
Ghazawi
FM
,
Alakel
A
,
Zubarev
A
,
Litvinov
IV
.
Geographic Variations in Cutaneous Melanoma Distribution in the Russian Federation
.
Dermatology
.
2020
Jun
;
•••
:
1
8
.
[PubMed]
1018-8665
23.
Chissov
VI
,
Starinsky
VV
,
Petrova
GV
. Malignant neoplasms in Russia in 2007 (morbidity and mortality). Moscow: FGU "Moscow Research Institute for them. P.A. Herzen Rosmedtekhnologii
2009
.
24.
Petrova
GV
,
Kaprina
AD
,
Gretsova
OP
,
Starinsky
VV
. Malignant neoplasms in Russia review of statistical information for 1993-2013. Moscow: P.A. Herzen branch of the FSBI "NMIRTS" of the Ministry of Health Russia;
2015
.
25.
Petrova
GV
,
Gretsova
OP
,
Kaprina
AD
,
Starinsky
VV
.
Characteristics and methods of calculating medical and statistical indicators used in oncology.
Moscow: FGBU MNII P.A. Herzen of the Ministry of Health of the Russian Federation;
2014
.
26.
Ghazawi
FM
,
Le
M
,
Alghazawi
N
,
Rahme
E
,
Moreau
L
,
Netchiporouk
E
, et al.
Trends in incidence of cutaneous malignant melanoma in Canada: 1992-2010 versus 2011-2015
.
J Am Acad Dermatol
.
2019
Apr
;
80
(
4
):
1157
9
.
[PubMed]
0190-9622
27.
Eayres
D
.
Commonly used public health statistics and their confidence intervals. Technical Briefing
.
Heslington, York
:
Public Health Observatories, Alcuin Research & Resource Centre, University of York
;
2008
.
28.
Hu
S
,
Parmet
Y
,
Allen
G
,
Parker
DF
,
Ma
F
,
Rouhani
P
, et al.
Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida
.
Arch Dermatol
.
2009
Dec
;
145
(
12
):
1369
74
.
[PubMed]
0003-987X
29.
Levi
F
,
Te
VC
,
Randimbison
L
,
Erler
G
,
La Vecchia
C
.
Trends in skin cancer incidence in Vaud: an update, 1976-1998
.
Eur J Cancer Prev
.
2001
Aug
;
10
(
4
):
371
3
.
[PubMed]
0959-8278
30.
Fears
TR
,
Scotto
J
.
Estimating increases in skin cancer morbidity due to increases in ultraviolet radiation exposure
.
Cancer Invest
.
1983
;
1
(
2
):
119
26
.
[PubMed]
0735-7907
31.
Del Bino
S
,
Duval
C
,
Bernerd
F
.
Clinical and Biological Characterization of Skin Pigmentation Diversity and Its Consequences on UV Impact
.
Int J Mol Sci
.
2018
Sep
;
19
(
9
):
E2668
.
[PubMed]
1661-6596
32.
Palkina
N
,
Sergeeva
O
,
Ruksha
T
,
Artyukhov
I
.
Melanoma Screening Day in Krasnoyarsk Krai of the Russian Federation: results from 2015-2016. Asian Pacific journal of cancer prevention
.
Asian Pac J Cancer Prev
.
2018
Feb
;
19
(
2
):
503
7
.
[PubMed]
2476-762X
33.
Bharath
AK
,
Turner
RJ
.
Impact of climate change on skin cancer
.
J R Soc Med
.
2009
Jun
;
102
(
6
):
215
8
.
[PubMed]
0141-0768
34.
Makin
J
.
Implications of climate change for skin cancer prevention in Australia
.
Health Promot J Austr
.
2011
Dec
;
22
(
Spec No
):
S39
41
.
[PubMed]
1036-1073
35.
Ferlay
J
.
CMaBF. Cancer Incidence in Five Continents, CI5plus: IARC CancerBase No. 9
[
Internet
]
Lyon, France
:
International Agency for Research on Cancer
;
2018
.
36.
Sanders
CM
,
Saltzstein
SL
,
Schultzel
MM
,
Nguyen
DH
,
Stafford
HS
,
Sadler
GR
.
Understanding the limits of large datasets
.
J Cancer Educ
.
2012
Dec
;
27
(
4
):
664
9
.
[PubMed]
0885-8195
37.
Emmons
KM
,
Colditz
GA
.
Preventing excess sun exposure: it is time for a national policy
.
J Natl Cancer Inst
.
1999
Aug
;
91
(
15
):
1269
70
.
[PubMed]
0027-8874
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.